Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H12N2O |
| Molecular Weight | 200.2365 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NCCC2=C1NC3=C2C=CC(O)=C3
InChI
InChIKey=RHVPEFQDYMMNSY-UHFFFAOYSA-N
InChI=1S/C12H12N2O/c1-7-12-10(4-5-13-7)9-3-2-8(15)6-11(9)14-12/h2-3,6,14-15H,4-5H2,1H3
| Molecular Formula | C12H12N2O |
| Molecular Weight | 200.2365 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms. | 2012-02 |
|
| Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006-11 |
|
| Anti-AIDS agents. 46. Anti-HIV activity of harman, an anti-HIV principle from Symplocos setchuensis, and its derivatives. | 2001-07 |
|
| Steroid hormone activity of flavonoids and related compounds. | 2000-07 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:58:42 GMT 2025
by
admin
on
Mon Mar 31 19:58:42 GMT 2025
|
| Record UNII |
2NQN80556Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2NQN80556Q
Created by
admin on Mon Mar 31 19:58:42 GMT 2025 , Edited by admin on Mon Mar 31 19:58:42 GMT 2025
|
PRIMARY | |||
|
C007904
Created by
admin on Mon Mar 31 19:58:42 GMT 2025 , Edited by admin on Mon Mar 31 19:58:42 GMT 2025
|
PRIMARY | |||
|
27943
Created by
admin on Mon Mar 31 19:58:42 GMT 2025 , Edited by admin on Mon Mar 31 19:58:42 GMT 2025
|
PRIMARY | |||
|
208-375-4
Created by
admin on Mon Mar 31 19:58:42 GMT 2025 , Edited by admin on Mon Mar 31 19:58:42 GMT 2025
|
PRIMARY | |||
|
DTXSID50894870
Created by
admin on Mon Mar 31 19:58:42 GMT 2025 , Edited by admin on Mon Mar 31 19:58:42 GMT 2025
|
PRIMARY | |||
|
525-57-5
Created by
admin on Mon Mar 31 19:58:42 GMT 2025 , Edited by admin on Mon Mar 31 19:58:42 GMT 2025
|
PRIMARY | |||
|
72293
Created by
admin on Mon Mar 31 19:58:42 GMT 2025 , Edited by admin on Mon Mar 31 19:58:42 GMT 2025
|
PRIMARY | |||
|
m5917
Created by
admin on Mon Mar 31 19:58:42 GMT 2025 , Edited by admin on Mon Mar 31 19:58:42 GMT 2025
|
PRIMARY | Merck Index | ||
|
3565
Created by
admin on Mon Mar 31 19:58:42 GMT 2025 , Edited by admin on Mon Mar 31 19:58:42 GMT 2025
|
PRIMARY | |||
|
Harmalol
Created by
admin on Mon Mar 31 19:58:42 GMT 2025 , Edited by admin on Mon Mar 31 19:58:42 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SOLVATE->ANHYDROUS | |||
|
SALT/SOLVATE -> PARENT |
|